Skip to main content

Warby Parker’s Q3 2026 earnings call: our top 5 analyst questions

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

WRBY Cover Image

Warby Parker’s Q3 results were well received by the market, with management attributing performance to a blend of retail expansion, accelerating e-commerce, and a growing focus on eye exams and insurance services. Co-CEO Dave Gilboa emphasized the importance of “investments in our most important long-term growth initiatives” and noted that e-commerce saw its strongest growth since the company sunset its Home Try-On offering. Management also highlighted robust adoption of new product collaborations, such as its fall assortment and the launch of Warby Parker Care, its first paid protection program.

Is now the time to buy WRBY? Find out in our full research report (it’s free for active Edge members).

Warby Parker (WRBY) Q3 2026 highlights:

  • Revenue $244.7 million vs S&P analyst consensus of $244.9 million (10.4% year-on-year growth, in line)
  • Adjusted EPS $0.12 vs S&P analyst consensus of $0.09 (30.2% beat)
  • Adjusted EBITDA $28.55 million vs analyst estimates of $26.91 million (11.7% margin, 6.1% beat)
  • Revenue guidance The company slightly lifted its revenue guidance for the full year to $971 million at the midpoint from $967.5 million
  • EBITDA guidance $118 million at the midpoint for the full year, above analyst estimates of $115.8 million
  • Operating margin 1.5%, in line with the same quarter last year
  • Active customers 2.74 million, up 80,000 year on year
  • Locations 364 at quarter end, up from 313 in the same quarter last year
  • Market capitalization $3.17 billion

While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our top 5 analyst questions from Warby Parker’s Q3 earnings call

  • Anthony Chukumba (Loop Capital Markets): Asked about sales cadence and early Q4 indications; Neil Blumenthal noted consistent trends but highlighted a slight slowdown in September that later moderated, attributing opportunities for market share gains to strong in-store conversion and higher average order values.
  • Brooke Roach (Goldman Sachs): Inquired about Intelligent Eyewear demo capacity and revenue contribution; Dave Gilboa emphasized that store footprint enables wide demo access, while Adrian Mitchell clarified that guidance assumes no halo effect from launch traffic on core business results.
  • Mark Altschwager (Baird): Sought clarity on Intelligent Eyewear production constraints and Q4 margin dynamics; management described near-term focus on customer experience, with 2027 the main year for scaling sales, and explained that Q4 margins reflect both recurring and one-time launch-related costs.
  • Dana Telsey (Telsey Advisory Group): Queried on Intelligent Eyewear pricing, cannibalization risk, and store operations; Gilboa said pricing details would follow soon, expects customers to use both traditional and intelligent eyewear, and Blumenthal described staff training and operational adjustments to support new product demos.
  • Janine Stichter (BTIG): Asked about marketing split and efficiency initiatives; management said most of the Google-funded marketing pool remains unspent, and Mitchell highlighted ongoing efforts to improve profitability through cost discipline and new product launches.

Catalysts in upcoming quarters

In the quarters ahead, our analysts will monitor (1) the pace of Intelligent Eyewear adoption and scaling of production, (2) the effectiveness of expanded marketing efforts in driving traffic and brand awareness, and (3) continued growth in insurance penetration and eye exam services. Progress on these fronts will be critical to validating Warby Parker’s strategy and sustaining momentum in a challenging retail environment.

Warby Parker currently trades at $25.45, up from $21.29 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).

The best stocks for high-quality investors

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  259.30
+0.00 (0.00%)
AAPL  342.37
+0.00 (0.00%)
AMD  449.04
+0.00 (0.00%)
BAC  49.42
+0.00 (0.00%)
GOOG  283.93
+0.00 (0.00%)
META  610.15
+0.00 (0.00%)
MSFT  530.61
+0.00 (0.00%)
NVDA  186.64
+0.00 (0.00%)
ORCL  116.10
+0.00 (0.00%)
TSLA  358.22
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.